ABSTRACT: Our objective in this study was to determine endocrine responses and changes in ovarian structures after a single injection of a GnRH agonist in Holstein dairy heifers (n = 38). Heifers were inseminated and received (i.rn.1 either saline or 200 pg of fertirelin acetate once on d 11, 12, or 13 after estrus (d 0). Blood was collected at 15-to 30-min intervals for 6 h after the injection to determine concentrations of LH, FSH, estradiol (E), and progesterone (PI in serum and once daily for 8 to 12 d after the injection to determine concentrations of E and P. Pregnancy rates were 58% (11 of 19) in both treatment groups. Diameter of the corpus luteum and numbers and appearance of ovarian follicles were determined by real-time ultrasonography on d -1 through 5 after injection. No treatment-induced ovulations or changes in the number of ovarian follicles were observed after the injection of the GnRH agonist. More (P < .05) of the largest follicles within heifers receiving fertirelin acetate showed changes in their appearance on at least the 1st d after injection (6 of 10 vs 1 of 9 control heifers). Fertirelin acetate induced release of LH and FSH from the pituitary within 15 min of injection both hormones reached peak concentrations at 120 min and then returned to pretreatment concentrations by 300 to 360 min after injection. Concentrations of E in serum were increased from 4 to 6 h after injection of the GnRH agonist but were lower U, < .051 for 8 to 12 d after injection than concentrations in control heifers, regardless of pregnancy status. Concentrations of P in serum were increased from 15 to 360 min after injection in all fertirelin-treated heifers. Pregnant heifers treated with fertirelin acetate had higher (P < .05) concentrations of P during 8 of 12 daily samples collected after the injection. Duration of the estrous cycle in nonpregnant heifers was unaltered by injection. In summary, 200 pg of the GnRH agonist fertirelin acetate released sufficient LH and FSH from the pituitary on d 11, 12, or 13 after estrus in inseminated heifers 11 to increase acutely concentrations of E and P during 6 h after injection, 2) to increase P in serum of pregnant heifers from 4 to 12 d after injection, and 3) to reduce significantly secretion of E by ovarian follicles for 8 to 12 d after injection. We conclude that reduced follicular secretion of E was associated with enhanced, but not prolonged, luteal function in heifers resulting from a single injection of a GnRH agonist administered on d 11 to 13 after estrus.
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Introduction Materials and Methods
In our previous study, the GnRH agonist fertirel i n acetate injected once between d 11 and 14 after estrus and insemination increased pregnancy rates in virgin beef heifers ' (Rettmer et al., 1992) . Injection of another GnRH agonist Buserelin) between d 11 and 13 after estrus in inseminated, lactating dairy cows resulted in higher pregnancy rates, extended interestrous intervals, and elevated concentrations of progesterone in serum, both acutely after injection and during several days thereafter (Macmillan et al., 1985a,b; . Furthermore, this treatment enabled the corpus luteum (CL) to rebut temporarily the luteolytic effects of prostaglandin Fza (PGFZa; Macmillan et al., 1985b) . Thatcher et al. (1989) proposed an antiluteolytic role of a midluteal injection of a GnRH agonist in which the surge-like release of LH from the pituitary either luteinized or ovulated midcycle follicles, thus altering follicular secretion of estradiol, which is necessary to initiate the uterine changes in oxytocin receptors and serum concentrations of PGFza preceding luteolysis (McCracken et al., 1984) . Luteinized follicles and(or1 accessory CL were observed after LH or GnRH treatments during the estrous cycle in cows (Berchtold et al., 19781, heifers [Thatcher et al., 19891, and sheep (Farin et al., 19881 , demonstrating that midcycle follicles respond similarly to an ovulatory follicle at estrus when exposed to a surge of FSH and LH. The LH surge induced by GnRH or one of its agonists also might provide a luteotropic stimulus to the CL. The luteotropic effect of exogenous LH or GnRH-induced LH release increased progesterone synthesis by the CL in cattle (Hansel and Seifart, 1967) and sheep (Farin et al., 1988 (Farin et al., , 1989 . Increased secretion of progesterone might be a luteoprotective mechanism to prevent luteal regression.
The objectives of our study were 1) to detennine the changes in LH, FSH, estradiol, and progesterone during 6 h after one injection of 200 pg of fertirelin acetate on d 11 to 13 after estrus, 2) to monitor concentrations of estradiol and progesterone for 8 to 12 d after the treatment injection, 3) to observe changes in ovarian structures (induced ovulations and changes in number and appearance of follicles) by real-time ultrasonography for several days after the injection, and 4) to correlate results to the increased pregnancy rates observed in virgin beef heifers treated with fertirelin acetate (Rettmer et al., 1992 Blood Collection. Blood samples, for measuring concentrations of estradiol and progesterone, were collected daily via coccygeal venipuncture beginning at estrus and continuing until 25 to 30 d after estrus. A subset of heifers (n = 211 was fitted with indwelling jugular catheters on the day before treatment and was placed in tie stalls with ad libitum access to water and alfalfa hay. Blood samples for determination of concentrations of LH, FSH, and progesterone were collected from jugular catheters every 30 min from -60 to 0 min (time of injectionl and then at intervals of 15 min for 3 h, followed by intervals of 30 min until 6 h after injection. Concentrations of estradiol were measured in samples collected at time of injection and 1, 2, 3, 4, 5, 6, and 12 h after injection. Blood was chilled on ice after collection, held at 4OC for 24 h until serum was obtained by centrifugation, and stored frozen at -2OOC until it was analyzed.
Hormone Analyses
Concentrations of progesterone (Skaggs et al., 1986) and estradiol (Mee et al., 1990) were quantified according to procedures previously validated in our laboratory. Intra-and interassay CV of two assays for estradiol averaged 12.3 and 12.8% and of 11 assays for progesterone averaged 5.5 and 510
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11.1Y0, respectively. Concentrations of LH in serum were determined by RIA described by Skaggs et al. (19861 with some modifications. Purified bovine LH (USDA-bLH-1-11 was used as the radioligand and standard reference preparation. Antisera were rabbit-anti-LH (USDA-309-684-PI and goatanti-rabbit gamma globulin (Lot #213-210; Chemicon International, El Segundo, CAI. The intraassay CV was 5.10/0, and the sensitivity of the assay was .39 ng/tube. Concentrations of FSH in serum were determined by a double-antibody RIA similar to that described by Newton et al. (19871 for porcine FSH but with modifications. Purified bovine FSH (USDA-bFSH-BP-31 was used as the radioligand and for the standard reference preparation. Antisera were rabbit-anti-bFSH (USDA-5-Pool-031789 P11 and the goat-anti-rabbit-gamma globulin. The intraassay CV was 5.4%, and the sensitivity of the assay was .96 ngitube.
Ovarian Examinations
A real-time, B-mode, diagnostic, ultrasound scanner (Equisonics lTokyo Keikil LSSOOA, Products Group International, Boulder, CO) equipped with a linear-array, 5-MHz, rectal transducer was used to monitor ovarian structures. The transducer was inserted rectally, moved along the dorsal surface of the reproductive tract for orientation, and then moved laterally to examine each ovary  . Ovarian scans were performed by one operator in one subset of 10 heifers on the day preceding (d -1) and d 1, 3, and 5 after injection of fertirelin acetate and in a second subset of nine heifers on d -1 through 4. All images were recorded on videotape and reviewed on a television monitor without knowledge of pregnancy status or treatment to determine numbers and appearance of follicles and diameters of follicular antra and CL. Changes in the follicular fluid (flocculence or cloudiness; Thatcher et al., 1989) and indistinct borders between antral fluid and surrounding tissue were defined to be changes in follicular appearance.
Statistical AnaIyses
All hormonal data were subjected to a least squares ANOVA using the GLM procedure of SAS (1982). Analysis of variance of the hormonal data collected during the 6-h sampling period after the injection of the GnRH agonist for FSH, LH, progesterone, and estradioI included treatment, animal within treatment, hour, and the hour x treatment interaction. Treatment was tested using the animal within treatment variance as the error term. A separate GLM procedure was used to determine the treatment effects on peak hormonal concentrations and time to peak concentration (maximal concentration during the 0-h period) and on duration of the estrous cycle and associated period of high progesterone in serum of nonpregnant heifers treated with saline or fertirelin acetate. Analysis of variance for daily concentrations of estradiol and progesterone (8 to 12 d after the injection of the GnRH agonist) was handled separately for nonpregnant and pregnant heifers, and the same model described above was used, substituting day for hour. Effects of treatment were tested by using the animal within treatment variance as the error term.
Analysis of the diameter of CL by the GLM procedure included treatment, day, animal within treatment, and treatment x day in the model, and animal within treatment variance was used as the error term to test for treatment effects on various days. Only measurements made on the day preceding (d -1) and d 1 and 3 after treatment in both subsets of scanned heifers were included in the analysis and expressed as a deviation from those measurements made on the day preceding treatment to account for pretreatment differences in initial diameters of structures on a within-heifer basis. Follicles were grouped into three classes according to estimated diameter of their follicular antra: small ( < 5 d , medium (5 to 10 mml, and large ( > 10 mm). Numbers of follicles after treatment were analyzed using the GLM procedure including treatment, class of follicles, day, and all two-and three-way interactions. A separate analysis was performed to determine treatment effects on the changes in diameter of the largest and second-largest follicle of each heifer identified on d -1, using the estimated beta coefficients resulting from regression curves that were fit to the daily changes in diameters of the two follicles on a within-heifer basis.
Results

Pregnancy Rates
Heifers were determined to be pregnant when concentrations of progesterone in serum remained well above 1 ng/mL (7.7 f .4 ng/mLl for at least 25 d after estrus and insemination. Pregnancy rates of heifers treated with fertirelin acetate (14 of 19, 74%) or saline (16 of 19,84%) were similar. A second pregnancy diagnosis by uterine palpation per rectum between 42 and 55 d after insemination found only 11 of 19 (58%) fertirelin acetate-treated heifers and 11 of 19 (58%) control heifers to be pregnant, indicating that some embryonic losses had occurred, with 21% (3/14) and 31% (5/10) of potential embryos lost, respectively. CConcentration of progesterone in serum > 1 ng/mL.
Duration of Luteal Function
Duration of luteal function in nonpregnant heifers was unaltered by the injection of the GnRH agonist ( Table 1 ). Heifers that returned to estrus in the normal range of 18 to 24 d (prompt return) and those that had concentrations of progesterone > 1 n g / d for more than 24 d but did not return to estrus in the normal range (prolonged return) had similar durations of elevated luteal-like concentrations of progesterone in their serum and similar duration of cycles, regardless of treatment.
Ovarian Follicles
Numbers of small (e5 mml, medium (5 to 10 mm), and large ( > 10 mml follicles on d -1, 1, and 3 after injection are summarized on a within-heifer basis in Table 2 . Treatment with fertirelin acetate failed to alter significantly the number of follicles per heifer within a given class on either day after injection. Postinjection changes in diameters of the largest and second-largest follicles were unaffected by fertirelin acetate from d -1 to 3 ( Table 2) . Although regressions representing daily changes in the diameter of the second-largest follicle appeared minimally different, those in the treated heifers tended to decline (p = -.03 f .2), whereas those in controls tended to increase (p = .15 f .21.
No sudden disappearance of medium or large follicles, indicative of a treatment-induced o d ation, was observed in either subset of heifers on d 1 through 5 after injection. Ultrasonographic examination indicated possible alterations in the appearance of the largest follicle ( > 10 mml present 24 h after injection in 6 of 10 heifers treated with fertirelin acetate compared with only one of nine control heifers (x2 = 5.12; P < .05). Observed changes included the loss of distinct borders of follicular antra and a change in the appearance of the follicular fluid from a clear black to a more opaque black color.
Corpus Luteum
Changes in diameter of the CL were similar between heifers receiving either saline or fertirelin acetate ( Table 2) . Diameters of CL did not change from preinjection values on d -1 but measurements decreased (P < .05) from d 1 to 3 after injection. When the initial differences in diameter between groups (favoring the controls in size) were accounted for by expressing measures as a deviation from the preinjection measurements, the results remained unchanged.
Hormonal Responses to Gonadotropin-Releasing Hormone Agonist
Luteinizing Hormone. Average concentrations of LH in serum for 360 min after injection of saline or fertirelin acetate are illustrated in Figure 1 . No significant changes in serum LH were observed in heifers injected with saline during the 6-h sampling period. Serum LH in those heifers receiving fertirelin acetate increased above that in controls (P < .01) within 15 min and remained elevated (P 
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Finure 3. Average hourlv concentrations of estradiol17p & serum of inseminatid dairy heifers from 0 to 6 h after saline (n -10) or 200 pg of fertirelin acetate (GnRH agonist) (n -11) given once on d 11 to 13 after estrus (SEM -f .7 ng/mL).
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.051 concentrations of estradiol in serum at 4 to 6 h after injection (Figure 31 , but concentrations of estradiol were similar again at 12 h after injection hot s h o d . Heifers treated with 200 pg of fertirel i n acetate showed a peak of estradiol (8.9 f 1.6 pg/mL1 at 4.4 f .6 h after treatment, whereas no changes in estradiol were observed in control heifers (Table 31 . Concentrations of estradiol in serum of nonpregnant, treated heifers were lower (P < .05) than concentrations in nonpregnant control heifers from 2 to 7 d after injection ( Figure  41 . Concentrations of estradiol in serum of pregnant, fertirelin acetate-treated heifers were less (P c .051 than those of pregnant, control heifers during 8 of 12 d after injection (Figure 5) . Progesterone. Concentrations of progesterone in serum increased within 15 min after injection of fertirelin acetate and remained elevated until 360 min postinjection (Figure 61 , regardless of pregnancy status. Heifers treated with fertirelin acetate had higher (P < .05) concentrations of progesterone in serum than control heifers from f5 to 360 min after treatment. Serum progesterone also tended (P = .061 to peak at higher concentrations than in controls (Table 31 . At 24 h after injection, all heifers had similar concentrations of progesterone in serum (Figures 4 and 51 .
In nonpregnant, control and fertirelin acetatetreated heifers, serum progesterone began to decrease approximately 3 to 5 d after treatment (Figure 41 , but heifers injected with fertirelin acetate seemed to have higher concentrations of 3) or 200 pg of fertirelin acetate (n = 5) given once on d 11 to 13 after estrus (SEM for P ranged from * .6 to * .8 ng/mL and SEM for E from f 1.6 to f 2.9 pg/mL).
progesterone at 7 and 8 d after treatment before concentrations decreased to < 1 ng/mL. However, these higher concentrations were observed in only two of five heifers treated with fertirelin acetate, which had concentrations of progesterone > 1 ng/ mL for 1 to 3 d longer than all remaining nonpregnant heifers. Pregnant heifers treated with fertirelin acetate had higher (P < .05) concentrations of progesterone in serum than pregnant controls from 4 to 12 d after injection, except on d 7 (Figure 51 .
Discussion
Treatment of inseminated dairy heifers with 200 pg of fertirelin acetate, a GnRH agonist, on either d 11, 12, or 13 after estrus induced the release of both LH and FSH from the pituitary. Magnitude and duration of the response and time to peak concentrations were within the range of values reported previously using the same dose of this GnRH agonist (Chenault et al., 19901 . The LH and FSH responses (magnitude and duration) to fertirel i n acetate seemed to be greater than those achieved with similar doses of the native hypothalamic decapeptide, GnRH (Zolrnan et al., 1074; Nawito et al., 1977;  Thompson et al., 1980; Chenault et al., 19901 but less than those observed after administration of 10 or 20 pg of buserelin during midcycle (Nawito et al., 1977;  Bostedt and Okyere, 1988; Chenault et al., 19901. The increased potency of GnRH agonists is ascribed to their reduced susceptibility to degradation by pituitary Days from Injection Figure 5 . Daily average concentrations of progesterone (P; nglmL) and estradiol (E; pg/mL) in serum of pregnant dairy heifers from -8 to + 12 d after treatment with saline (n -16) or 200 pg of fertirelin acetate (n -14) given once on d 11 to 13 after estrus (SEM for P were k .4 nglmL and SEM for E were * .9 to f 1.4 pg/ mL) .
endopeptidases &asdun and Orlowski, 19901. Despite increasing LH content in the pituitary throughout the luteal phase of the estrous cycle (Clark, 19891, there was no difference in the LH response to GnRH among days of the luteal phase in sheep (Reeves et al., 19711, cows (Foster et al., 19801, or heifers (Chenault et al., 1990) .
The surge of gonadotropin released by fertirelin acetate induced both short-and long-term changes in secretion of ovarian steroids (Figures 3 to 6) . Midcycle follicles possess gonadotropin receptors and are estrogen-active [Ireland and Roche, 19831, whereas the CL contains LH receptors in the small luteal cells that respond to pituitary gonadotropin (Niswender et al., 1985) . Ovarian follicles and CL secrete pulses of estradiol and progesterone, respectively, within a few minutes (progesterone) to an hour (estradiol), in response to endogenous pulses of gonadotropin (Walters et al., 1984) . These pulses are only detectable in the utero-ovarian venous effluent. Concentrations of progesterone in our heifers were increased within 15 min after injection of fertirelin acetate, remained elevated above those of controls until 6 h after injection (Figure 61 , and then returned to concentrations similar to those observed in controls by 24 h. Short-term increases in concentrations of progesterone in serum after native GnRH also have been reported (Kittok et al., 1973; Zolman et al., 1974; Foster et al., 1980;  Thompson et al., 1980; Macmillan et al., 1985a) . Increased progesterone usually was observed within 30 min to 6 h after treatment in those studies. This short-term increase in progesterone may be explained by the response of 
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Minutes after Injection Figure 6 . Concentrations of progesterone in serum of inseminated dairy heifers during 6 h after saline (n -10) or 200 pg of fertirelin acetate (GnRH agonist) (n -11) given once on d 11 to 13 after estrus (SEM -* .3 ng/mL) .
the small luteal cells of the CL, which contain the majority of the LH receptors (Niswender et al., 1985; Farin et al., 1988, 19891 , to the secretion of LH induced by the GnRH agonist. Pregnant heifers treated with fertirelin acetate had increased concentrations of progesterone in serum above those of controls by 4 d after treatment (Figure 51 , and concentrations remained increased for another 8 d when sampling was terminated. Ultrasonographic evaluation of the ovaries after treatment failed to reveal any difference in diameter of the CL between the two groups of heifers. However, the ovarian examinations were terminated near the time the first long-term changes in progesterone (4 d after injection] were observed in pregnant heifers.
Others also have reported increased progesterone for several days after administration of a GnRH agonist (Milvae et al., 1984; Macmillan et al., 1985a1 , whereas in one study no such differences were observed (Bostedt and Okyere, 19881 , and reduced concentrations in progesterone were reported when native GnRH was injected early (d 2) during the cycle in heifers (Ford and Stormshak, 1978;  Rodger and Stormshak, 1986) . Injections of LH have been shown to stimulate the transformation of small luteal cells to large luteal cells (Niswender et al., 1985; Farin et al., 19881 , which have higher basal secretion of progesterone but eventually lose their ability to respond to LH.
Thus, increased numbers of large luteal cells may explain the observed long-term increase in progesterone in heifers treated with fertirelin acetate or other GnRH agonists. The short-and long-term increase in progesterone also might be explained by possible peripheral luteinization of follicles orchestrated by the fertirelin acetate-induced release of LH. Whether our subjective observations of changes in appearance of the borders of follicular antra and in opaqueness of follicular fluid is indicative of luteinization remains to be verified; however, similar observations were reported in another study using buserelin (Thatcher et al., 1989) .
Concentrations of progesterone tended to be similar after injection of nonpregnant heifers with fertirelin acetate or saline. The tendency for a delayed decline in progesterone to < 1 ng/mL observed at the time of luteolysis (Figure 4) for heifers treated with fertirelin acetate was due to only two of five heifers with longer interestrous intervals of 1 and 3 d. Macmillan et al. (198513) reported that a GnRH agonist (buserelinl given to cows on d 12 of the estrous cycle, from 15 min to 72 h before an injection of PGFa,, not only delayed the decline in serum concentrations of progesterone but also retarded regression of the CL and increased (by 3.4 d intervals to estrus compared with controls given only PGF2,. Their observations indicated a possible luteoprotective mechanism capable of preventing complete and rapid luteolysis in their cows treated with buserelin.
Both short-and long-term changes in ovarian estradiol secretion were observed in heifers treated with fertirelin acetate. After preinjection differences in concentrations of estradiol were accounted for in the statistical analysis, the treated heifers had increased concentrations of estradiol after the injection of the GnRH agonist, reaching a peak between 4 and 6 h (Figure 3) . The observed short-term increase in concentrations of estradiol may be explained by increased follicular secretion of estradiol in response to the GnRHinduced gonadotropin release, similar to that normally observed during proestrus. In contrast, during the next 8 to 12 d, independent of pregnancy status, concentrations of estradiol were reduced markedly in heifers treated with the GnRH agonist, beginning 3 to 4 d after treatment (Figures 4 and 5) . Other studies using GnRH treatments during the estrous cycle did not report concentrations of estradiol, but when 10,000 IU of hCG was given on d 10 of the estrous cycle, an increase in estradiol between d 16 and 20 was observed i n control heifers but not in hCGtreated heifers (Howard et al., 1990) . Altered secretion of estradiol induced by the midcycle injection of either hCG or the GnRH agonist may prevent upregulation of uterine receptors for estradiol and oxytocin, which are apparently prerequisite for the luteolytic, uterine PGFzdovarian oxytocin cascade (McCracken et al., 19841 . Extended exposure to gonadotropin might luteinize subsequently all or some follicles, thereby eliminating their estrogen secreting activity (Ireland and Roche, 1982) . Luteinized follicles (Schwarz et al., 1984) or paracyclic ovulations induced by midcycle injections of a GnRH agonist (Berchtold et al., 1978;  Thatcher et al., 19891 might reduce estrogen secretion from the ovary.
A possible dose-dependent luteinization and(or1 induced ovulation of midcycle antral follicles might explain the lack of increased estradiol in those heifers that received GnRH or its agonist. However, no induced ovulations nor changes in distribution of follicles per class were detected during 3 or 5 d after treatment in our study. We admittedly have reservations about possible changes in the reported appearance of follicles in the present study and elsewhere (Thatcher et al., 1989) because of the potential for bias by the ultrasound operator and the technical difficulty of achieving adequate resolution of ovarian follicles.
However, when our video recordings were analyzed without knowledge of treatment or pregnancy status, it appeared that more heifers treated with fertirelin acetate (6 of 10) showed a qualitative change in their largest follicle than control heifers [one of nine). These observed changes (i.e., less distinct antral walls and cloudiness or more opaqueness of the follicular fluid) might be interpreted to be signs of luteinization or follicular atresia (Thatcher et al., 19891, accounting for the observed lowered concentrations of estradiol in the serum of our treated heifers.
Thatcher et al. (1989) observed ultrasonographically greater numbers of "cloudy" follicles on the ovaries of heifers treated with buserelin and postulated these to be luteinized and(or1 atretic follicles, thereby relegating these follicles to an estrogen-inactive status Roche, 1982, 1983) . Obliteration of antral follicles on both ovaries by electrocautery and(or1 subsequent xirradiation on d 9, 12, or 15 of the estrous cycle delayed luteolysis and extended the cycle (VillaGodoy et al., 1985; Hughes et al., 1987) . Although duration of the estrous cycle in our study was not prolonged, a decrease in estradiol and enhanced secretion of progesterone in pregnant heifers was observed, consistent with the postulate of Thatcher et al. (1989) . Incidence of estrous cycles of c 2 0 d in dairy cows was reduced (Macmillan et al., 1985a1 and duration of cycles prolonged in inseminated heifers increased (Thatcher et al., 19901 when buserelin was administered once between d l l and 13 after estrus. We attribute the lack of a significant increase in cycle duration in our nonpregnant heifers to the lower potency of fertirelin acetate compared with buserelin, as demonstrated previously (Chenault et al., 1990) . However, we observed earlier a tendency for a linear increase in cycle length (by 2 d of heifers treated with 100-and 200-pg doses of fertirelin acetate CRettmer et al., 1992) .
We failed to observe increased pregnancy rates in the present study, in which dairy heifers were treated with 200 pg of fertirelin acetate. In contrast, we observed higher pregnancy and calving rates across five locations in over 600 virgin beef heifers treated with either 100 or 200 pg of the same GnRH agonist in our earlier report (Rettmer et al., 1992) . We found that 100 pg increased pregnancy rates in three of five locations and 200 pg was effective in three of five locations, with both doses effective at two of five locations. Two previous studies failed to show increased pregnancy rates when a GnRH agonist (10 pg of buserelinl was injected on d 11 to 13 after estrus and insemination (Jubb et al., 1990; Thatcher et al., 19901. Although there was no overall effect of the GnRH agonist in all 19 herds in the former study (Jubb et al., 19901, there were increased pregnancy rates in some herds, agreeing with our findings in heifers cited above and in another study of lactating dairy cows (Macmillan et al., 1986) . It remains unclear why there was a positive effect of these GnRH agonists in some herds but not in others. Further study seems to be warranted to determine what factods) are involved in eliciting this profertility effect in some herds.
Implications
The findings of the present study support the proposed luteotropic effects of gonadotropin-releasing hormone (GnRH) or one of its agonists following a midcycle injection because progesterone secretion by the corpus luteum was increased not only shortly after administration of the GnRH agonist, but also for up to 12 d in pregnant heifers.
This increase in progesterone could be viewed as further evidence for a luteoprotective effect of the GnRH agonist, in addition to its attenuating effect (and antiluteolytic role1 on the secretion of estradiol. The luteoprotective and antiluteolytic properties of GnRH agonists may explain why increased pregnancy rates have been observed after midcy cle injections in some studies in which developmentally retarded embryos might be allowed additional time to establish the signals for maternal recognition of pregnancy.
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